May & Baker Nigeria Plc is leveraging on its investment in a multi-billion naira world class pharmaceutical manufacturing facility to steadily grow turnover and profit despite the challenging business environment in the country.
The unaudited financial results of the 9 months of 2015 show that May &Baker made 9 per cent growth in turnover and 165 per cent growth in profit when compared with the same period in 2014. The results which were recently published by the Nigerian Stock Exchange show a turnover of N5.3 billion and N60.63 million profits for the period, January to September, 2015 compared to a revenue of N4.8 billion and loss of N93.5 million for the same period in 2014.
The group results from January to September shows improvement in all fundamentals, a trend which started in the last quarter of 2014 and significantly improved by the first half of 2015.
Join Daily Trust WhatsApp Community For Quick Access To News and Happenings Around You.
